Article
Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma.
The American journal of surgical pathology - 1 Dec 2002
Niedergethmann Marco, Rexin Martin, Hildenbrand Ralf, Knob Stefanie, Sturm Jörg W, Richter Axel, Post Stefan
Abstract excerpt
Cure for ductal adenocarcinoma of the pancreas is restricted to resectable tumors, but survival after surgery is still poor. Despite apparently curative resection, these cancers rapidly recur. Thus, the present pathologic examination should be enriched by sensitive methods to detect minimal residual disease. In a prospective setting we studied the frequency of minimal residual disease after curative resection by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.